Company Filing History:
Years Active: 2021-2025
Title: **Innovator Spotlight: Huifeng Han**
Introduction
Huifeng Han is an accomplished inventor based in Beijing, China, known for his significant contributions to the field of pharmaceutical chemistry. With a total of two patents to his name, Han has been instrumental in advancing therapeutic options for diseases associated with SHP2-mediated disorders.
Latest Patents
Han's recent patents focus on heterocyclic derivatives that serve as SHP2 inhibitors. The first patent describes a compound of formula I, detailing its synthesis and its application in creating a pharmaceutical composition aimed at treating SHP2 mediated disorders. The second patent categorizes novel pyrazine derivatives also as SHP2 inhibitors, providing methods for their synthesis and strategies for utilizing these compounds in treating related disorders. Both inventions underline Han's expertise in developing innovative solutions for complex health issues.
Career Highlights
Currently, Huifeng Han is associated with Jacobio Pharmaceuticals Co., Ltd., where he leverages his extensive knowledge and research skills in drug development. His work has emphasized the importance of targeting SHP2 in therapeutic interventions, showcasing his commitment to enhancing patient care through innovative approaches.
Collaborations
Throughout his career, Han has collaborated with notable colleagues, including Cunbo Ma and Panliang Gao. These partnerships have contributed to a dynamic research environment, fostering innovation and translating scientific discoveries into viable health solutions.
Conclusion
Huifeng Han exemplifies the spirit of innovation in the field of pharmaceuticals. With his groundbreaking patents and partnerships, he continues to pave the way for advancements that address critical health challenges. His dedication as an inventor underlines the impact that innovative research can provide in the medical field.